Thermo Fisher Scientific Inc
About
Thermo Fisher Scientific Inc (NYSE:TMO) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
Apr 23 2026
Thermo Fisher Scientific Reports First Quarter 2026 Results
Apr 21 2026
Biotechnology Instruments Market Analysis Report 2026-2035: Unified Frameworks Combining Genomics and Proteomics Underpin New Strategic Market Developments
Apr 16 2026
Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity
Apr 13 2026
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities
Financials
Revenue
$44.56 B
Market Cap
$182.57 B
P/E Ratio
27.70
EPS
17.74
Dividend Yield
0.35%